Table 1 The baselines of demographics, IBS medical history, and IBS symptoms (intention-to-treat population).

From: Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial

Characteristic

Pinaverium (n = 132)

Placebo (n = 132)

P value

Age, mean ± SD

41.8 ± 14.0

38.9 ± 13.7

0.09

Male, n (%)

54 (41%)

51 (39%)

0.71

Female, n (%)

78 (59%)

81 (61%)

 

IBS history, years ± SD

4.92 ± 4.42

4.98 ± 3.91

0.91

Abdominal pain, mean ± SD

4.92 ± 1.50

5.03 ± 1.62

0.58

Stool consistency, mean ± SD

6.10 ± 0.83

6.01 ± 0.76

0.35

Pain frequency, mean ± SD

4.66 ± 1.54

4.56 ± 1.54

0.60

Stool frequency, mean ± SD

4.36 ± 1.06

4.15 ± 1.09

0.12

Global overall symptom scale, mean ± SD

2.55 ± 0.89

2.55 ± 0.81

0.94

  1. Chi-square for genders; T-test for others.
Back to article page